President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...

Indian stock markets experienced a decline on Wednesday as tensions in the Middle East escalated. Crude oil prices surged above $92 a barre...

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...

Donald Trump is likely planning new import duties on many nations by Friday. These levies aim to continue his tariff regime after current o...

Activists demonstrated in New York and San Jose supporting Sonam Wangchuk's hunger strike. Protests occurred in London and Dublin, demandin...

President Trump approved a Saudi nuclear deal potentially granting enrichment capability. This agreement, lasting thirty years, involves U....

President Trump directed US airlines to fly directly to Lebanon. Flights were suspended in 1985 after a hijacking incident. Extensive secur...

The United States is imposing a 50% tariff on many Canadian goods. This follows Canada's alleged discriminatory treatment of American cars ...

Alembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...

India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...

Indian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...

South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...

Leading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...

Industry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s...